FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

177511000001108: Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17331901000001117 Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37724901000001118 Cyproterone 50mg tablets (Wockhardt UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) Is a Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) Has active ingredient Cyproterone acetate false Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) Has specific active ingredient Cyproterone acetate true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is pack of False Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) 168 tablet 12 x 14 tablets Is pack of False Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has AMP True Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) 168 tablet 12 x 14 tablets Has AMP True Cyproterone 50mg tablets (C P Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start